Oral antibiotics to prevent postoperative urinary tract infection: A randomized controlled trial

Obstetrics and Gynecology

Volumn 123, Issue 1, 2014, Pages 96-103

  Dieter, Alexis A ^a   Amundsen, Cindy L ^a   Edenfield, Autumn L ^a   Kawasaki, Amie ^a   Levin, Pamela J ^a   Visco, Anthony G ^a   Siddiqui, Nazema Y ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN; PLACEBO;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM CULTURE; CATHETERIZATION; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MIDDLE AGED; OUTCOME ASSESSMENT; PELVIS SURGERY; POSTOPERATIVE INFECTION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; URETHRAL CATHETERIZATION; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS, URINARY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NITROFURANTOIN; PELVIC ORGAN PROLAPSE; POSTOPERATIVE COMPLICATIONS; TREATMENT FAILURE; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 84893645227     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000024     Document Type: Article

References (29)

1. Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review. Neurourol Urodyn 2008;27:738-46.
2. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991;91: 65S-71S.
3. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 2008:1-29.
4. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(suppl 1A): 5S-13S.
5. Chung CP, Kuehl TJ, Harris SK, McBride MM, Larsen WI, Yandell PM, et al. Incidence and risk factors of postoperative urinary tract infection after uterosacral ligament suspension. Int Urogynecol J 2012;23:947-50.
6. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008;300:1311-6.
7. Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J 2010; 21:955-61.
8. Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K, et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med 2012;366:2358-67.
9. Fok CS, McKinley K, Mueller ER, Kenton K, Schreckenberger P, Wolfe A, et al. Day of surgery urine cultures identify urogynecologic patients at increased risk for postoperative urinary tract infection. J Urol 2013;189:1721-4.
10. Ingber MS, Vasavada SP, Firoozi F, Goldman HB. Incidence of perioperative urinary tract infection after single-dose antibiotic therapy for midurethal slings. Urology 2010;76:830-4.
11. Nygaard I, Brubaker L, Chai TC, Markland AD, Menefee SA, Sirls L, et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J 2011;22:1255-65.
12. Schiotz HA, Malme PA, Tanbo TG. Urinary tract infections and asymptomatic bacteriuria after vaginal plastic surgery. A comparison of suprapubic and transurethral catheters. Acta Obstet Gynecol Scand 1989;68:453-5.
13. Schiotz HA, Tanbo TG. Postoperative voiding, bacteriuria and urinary tract infection with Foley catheterization after gynecological surgery. Acta Obstet Gynecol Scand 2006;85:476-81.
14. Stekkinger E, van der Linden PJ. A comparison of suprapubic and transurethral catheterization on postoperative urinary retention after vaginal prolapse repair: a randomized controlled trial. Gynecol Obstet Invest 2011;72:109-16.
15. Jackson D, Higgins E, Bracken J, Yandell PM, Shull B, Foster RT, et al. Antibiotic prophylaxis for urinary tract infection after midurethral sling: a randomized controlled trial. Female Pelvic Med Reconstr Surg 2013;19:137-41.
16. Foster RT Sr, Borawski KM, South MM, Weidner AC, Webster GD, Amundsen CL. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007;197: 627.e1-4.
17. Hakvoort RA, Thijs SD, Bouwmeester FW, Broekman AM, Ruhe IM, Vernooij MM, et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG 2011;118:1055-60.
18. Hakvoort RA, Burger MP, Emanuel MH, Roovers JP. A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009;20: 813-8.
19. Phipps S, Lim YN, McClinton S, Barry C, Rane A, N'Dow J. Short term urinary catheter policies following urogenital surgery in adults. The Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004374. DOI: 10.1002/14651858. CD004374.pub2.
20. Healy EF, Walsh CA, Cotter AM, Walsh SR. Suprapubic compared with transurethral bladder catheterization for gynecologic surgery: a systematic review and meta-analysis. Obstet Gynecol 2012;120:678-87.
21. Sutkin G, Lowder JL, Smith KJ. Prophylactic antibiotics to prevent urinary tract infection during clean intermittent selfcatheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:933-8.
22. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998;25:723-46.
23. Wu JM, Kawasaki A, Hundley AF, Dieter AA, Myers ER, Sung VW. Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. Am J Obstet Gynecol 2011;205:230.e1-5.
24. Dieter AA, Amundsen CL, Visco AG, Siddiqui NY. Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery. Female Pelvic Med Reconstr Surg 2012;18:175-8.
25. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010;115:1063-70.
26. van der Wall E, Verkooyen RP, Mintjes-de Groot J, Oostinga J, van Dijk A, Hustinx WN, et al. Prophylactic ciprofloxacin for catheterassociated urinary-tract infection. Lancet 1992;339:946-51.
27. Rogers RG, Kammerer-Doak D, Olsen A, Thompson PK, Walters MD, Lukacz ES, et al. A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. Am J Obstet Gynecol 2004;191:182-7.
28. Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 2007;356: 2143-55.
29. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002;287:2701-10.